The global nephrostomy devices market size is anticipated to reach USD 2.32 billion by 2030 registering a CAGR of 7.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing awareness about nephrostomy devices among physicians and rising cases of kidney stone disease are driving the market. Increasing prevalence of ovarian, bladder, and prostate cancers and improving healthcare infrastructure in the developing economies are also among the key factors fueling the market growth.
North America is expected to register the highest market share owing to increasing prevalence of kidney stone disorder and ovarian, bladder, and prostate cancers. For instance, according to the American Cancer Society, around 22,240 new cases of ovarian cancer were diagnosed in 2018 in U.S. Major companies in this market are emphasizing on new product launches and innovations in the existing products. For instance, in February 2017, Cook Medical introduced Universa along with the two sets of percutaneous urinary drainage.
Request a free sample copy or view report summary: Nephrostomy Devices Market Report
Guidewires dominated the market and accounted for a market share of 28.7% in 2023. It can be attributed to the rising geriatric population, improved hospital infrastructure, and technological advancements.
Nephrostomy catheters are expected to grow at a significant CAGR over the forecast period. It can be attributed to the rising cases of kidney stones & urinary tract infections in both men and women.
Hospitals dominated the market and accounted for a market share of 69.3% in 2023. Hospitals typically have access to the latest innovations in nephrostomy technology.
North America nephrostomy devices market dominated in 2023. It can be attributed to the increasing prevalence of chronic kidney diseases in the region.
Grand View Research has segmented the global nephrostomy devices market on the basis of product, end use, and region:
Nephrostomy Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Guidewires
Drainage Tubes
Nephrostomy Catheters
Sheath Dilators
Others
Nephrostomy Devices End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital
Emergency Clinics
Ambulatory Surgical Centers (ASCs)
Nephrostomy Devices Regional Outlook (Revenue, USD Million; 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Nephrostomy Devices Market
Boston Scientific Corporation
Teleflex Incorporated.
Cardinal Health.
BD
Cook Medical
B. Braun Melsungen AG
Coloplast Group
Olympus Corporation
Argon Medical Devices.
UreSil LLC
"The quality of research they have done for us has been excellent..."